Antibiotic therapy for Klebsiella pneumoniae bacteremia: implications of production of extended-spectrum beta-lactamases.
By David L. Paterson, W. Ko, A. von Gottberg, Sunita Mohapatra, J. Casellas, H. Goossens, L. Mulazımoglu, G. Trenholme, K. Klugman, Robert A. Bonomo and 4 more. Clinical Infectious Diseases, 2004
604 citations recorded by the source corpus.
Subfields: Applied Microbiology and Biotechnology, Molecular Medicine, Pharmacology
View Paper: https://www.semanticscholar.org/paper/96230d0688b6afd4b7b52e03d39208d82d803d05
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Applied Microbiology and Biotechnology
In Molecular Medicine
Citations in the corpus
- The relationship between antimicrobial resistance and patient outcomes: mortality, length of hospital stay, and health care costs. (2006, background): “[48] observed that failure to treat with an appropriate antimicrobial agent (i.”
- Mortality and delay in effective therapy associated with extended-spectrum beta-lactamase production in Enterobacteriaceae bacteraemia: a systematic review and meta-analysis. (2007, background): “Moreover, not all apparently appropriate therapies are equally effective versus ESBL producers, and variability in outcomes has been noted even according to the class of agent used, with carbapenems the most reliable class for treatment of ESBL infections.(34,35) An additional factor that may influe”